Point-of-care hemoglobin A1c margin of error alters resident management of Type 2 diabetes when near glycemic target
Point-of-care (POC) HbA1c is frequently used as a surrogate for serum HbA1c. We aimed to determine if resident management of type 2 diabetes changed after accounting for the + 0.5% margin of error associated with POC HbA1c devices.
Source: Primary Care Diabetes - Category: Primary Care Authors: Samuel G. Cook, Lauren M. Gin, Alexandra K. Taylor, Ronald J. Markert, John G. Hughes Source Type: research